Emmaus Life Sciences, Inc.
EMMA · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$6,453 | -$3,733 | -$10,625 | -$15,946 |
| Dep. & Amort. | $22 | $32 | $53 | $59 |
| Deferred Tax | $0 | -$100 | $0 | $9,660 |
| Stock-Based Comp. | $256 | $1,262 | $16 | $553 |
| Change in WC | $4,200 | -$2,617 | $2,209 | $2,110 |
| Other Non-Cash | -$311 | $3,653 | $3,274 | $2,310 |
| Operating Cash Flow | -$2,286 | -$1,503 | -$5,073 | -$1,254 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$12 | -$17 | -$26 | -$73 |
| Net Acquisitions | $0 | $0 | $5,280 | $0 |
| Inv. Purchases | $0 | $0 | -$5,280 | -$6,304 |
| Inv. Sales/Matur. | $2,508 | $2,232 | $2,919 | $0 |
| Other Inv. Act. | $4 | -$2,647 | -$5,280 | -$6,304 |
| Investing Cash Flow | $2,500 | -$432 | -$2,387 | -$6,377 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,353 | $2,477 | $7,233 | $7,411 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | -$1,353 | $2,477 | $7,233 | $7,411 |
| Forex Effect | -$19 | -$16 | -$31 | $12 |
| Net Chg. in Cash | -$1,158 | $526 | -$258 | -$208 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,547 | $2,021 | $2,279 | $2,487 |
| End Cash | $1,389 | $2,547 | $2,021 | $2,279 |
| Free Cash Flow | -$2,298 | -$1,520 | -$5,099 | -$1,327 |